Search in:

Drug, Healthcare and Patient Safety Volume 12, 2020 - Issue

Submit an article Journal homepage

Open access

228

Views

CrossRef citations to date

Altmetric

Review

Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis

Swati Gulati1 Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USACorrespondence[email protected]

Tracy R Luckhardt1 Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA;2 Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

Pages 85-94 | Published online: 07 May 2020

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (20)

Zijiao Zhang, Juhan Song, Seung-Hee Kwon, Zhao Wang, Suk-Gyun Park, Xianyu Piao, Je-Hwang Ryu, Nacksung Kim, Ok-Su Kim, Sun-Hun Kim & Jeong-Tae Koh. (2023) Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice. International Journal of Molecular Sciences 24:10, pages 8682.
Crossref

Sujeet K. Rajan, Vincent Cottin, Raja Dhar, Sonye Danoff, Kevin R. Flaherty, Kevin K. Brown, Anant Mohan, Elizabeth Renzoni, Murali Mohan, Zarir Udwadia, Padmanabha Shenoy, David Currow, Anand Devraj, Bhavin Jankharia, Ritu Kulshrestha, Steve Jones, Claudia Ravaglia, Silvia Quadrelli, Rajam Iyer, Sahajal Dhooria, Martin Kolb & Athol U. Wells. (2023) Progressive pulmonary fibrosis: an expert group consensus statement. European Respiratory Journal 61:3, pages 2103187.
Crossref

Huei-Jyuan Pan, Chia-Wei Lee, Li-Yu Wu, Heng-Hua Hsu, Yi-Chung Tung, Wei-Yu Liao & Chau-Hwang Lee. (2023) A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts. APL Bioengineering 7:1, pages 016117.
Crossref

Hana Alsomali, Evelyn Palmer, Avinash Aujayeb & Wendy Funston. (2023) Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review. Pulmonary Therapy.
Crossref

Francesc Alamon-Reig, Laura Serra-Garcia, Ignasi Martí-Martí & Paula Aguilera-Peiró. (2023) Reacción fototóxica por pirfenidona. Piel 38:1, pages 25-27.
Crossref

Fabian Philipp Kreutzer, Anna Meinecke, Saskia Mitzka, Hannah Jill Hunkler, Lisa Hobuß, Naisam Abbas, Robert Geffers, Jan Weusthoff, Ke Xiao, Danny David Jonigk, Jan Fiedler & Thomas Thum. (2022) Development and characterization of anti-fibrotic natural compound similars with improved effectivity. Basic Research in Cardiology 117:1.
Crossref

Suyeon Cho, Sunju Park, Ju Ah Lee, Hee-Jae Jung, Kwan-Il Kim & Beom-Joon Lee. (2022) The Efficacy and Safety of Herbal Medicine with Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review. Processes 10:12, pages 2477.
Crossref

Ladan Panahi, George Udeani, Andrew Scott Tenpas, Theresa Ofili, Elizabeth Marie Aguilar, Sarah Burchard, Alexandra Ruth Ritenour, April Jacob Chennat, Nehal Ahmed, Chairat Atphaisit, Crystal Chi, Jesus Cruz III, Monica D. Deleon, Samantha Lee, Zack Mayo, Mackenzie Mcbeth, Mariel Morales, Jennifer N. Nwosu, Kelly Palacios, Jaycob M. Pena & Nitza Vara. 2022. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.

Yinghan Chan, Sachin Kumar Singh, Monica Gulati, Sheetu Wadhwa, Parteek Prasher, Deepak Kumar, Avvaru Praveen Kumar, Gaurav Gupta, Gowthamarajan Kuppusamy, Mehra Haghi, Brian Gregory George Oliver, Jon Adams, Dinesh Kumar Chellappan & Kamal Dua. (2022) Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases. Journal of Drug Delivery Science and Technology 74, pages 103541.
Crossref

Joseph Kelich, Tomas Aramburu, Joanne J. van der Vis, Louise Showe, Andrew Kossenkov, Jasper van der Smagt, Maarten Massink, Angela Schoemaker, Eric Hennekam, Marcel Veltkamp, Coline H.M. van Moorsel & Emmanuel Skordalakes. (2022) Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis. Journal of Experimental Medicine 219:5.
Crossref

Alberto Aimo, Giosafat Spitaleri, Dari Nieri, Laura Maria Tavanti, Claudia Meschi, Giorgia Panichella, Josep Lupón, Francesco Pistelli, Laura Carrozzi, Antoni Bayes-Genis & Michele Emdin. (2022) Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond. Cardiac Failure Review 8.
Crossref

Adolf Koudelka, Veronika Cechova, Mauricio Rojas, Nilay Mitash, Anna Bondonese, Claudette St. Croix, Mark A. Ross & Bruce A. Freeman. (2022) Fatty acid nitroalkene reversal of established lung fibrosis. Redox Biology 50, pages 102226.
Crossref

Ava C. Wilson, Joe Chiles, Shah Ashish, Diptiman Chanda, Preeti L. Kumar, James A. Mobley, Enid R. Neptune, Victor J. Thannickal & Merry-Lynn N. McDonald. (2022) Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs. Scientific Reports 12:1.
Crossref

Ramin Rezaee & Hossein Hosseinzadeh. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 803 811 .

Susan Monkley, Catherine Overed-Sayer, Helen Parfrey, Doris Rassl, Damian Crowther, Leire Escudero-Ibarz, Nicola Davis, Alan Carruthers, Richard Berks, Marisa Coetzee, Ewa Kolosionek, Maria Karlsson, Leia R. Griffin, Maryam Clausen, Graham Belfield, Cory M. Hogaboam & Lynne A. Murray. (2021) Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF. Scientific Reports 11:1.
Crossref

Daniel Morgado‐Carrasco, Jaume Massana & Jaime Piquero‐Casals. (2020) Pirfenidone‐induced phototoxic reaction. International Journal of Dermatology 60:5.
Crossref

Xin Luo, Qiangqiang Deng, Yaru Xue, Tianwei Zhang, Zhitao Wu, Huige Peng, Lijiang Xuan & Guoyu Pan. (2021) Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-βRI/Smad Signaling. Molecules 26:6, pages 1715.
Crossref

N. A. Kuzubova, O. N. Titova & D. B. Skliarova. (2020) Interstitial lung diseases with progressive pulmonary fibrosis: pathogenetic features and approaches to therapy. Meditsinskiy sovet = Medical Council:17, pages 99-106.
Crossref

Evgenii Skurikhin, Vladimir Nebolsin, Darius Widera, Natalia Ermakova, Olga Pershina, Angelina Pakhomova, Vyacheslav Krupin, Edgar Pan, Mariia Zhukova, Fedor Novikov, Lubov Sandrikina, Sergey Morozov, Aslan Kubatiev & Alexander Dygai. (2020) Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis. International Journal of Molecular Sciences 21:21, pages 8380.
Crossref

Yanqiu Lan, Dezhi Wu, Yunrui Jin, Min Shui & Xianjun Fan. (2020) Danhong injection in the treatment of idiopathic pulmonary fibrosis. Medicine 99:37, pages e22016.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis

Articles from other publishers (20)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis

Citations (20)

Articles from other publishers (20)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date